Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
February 22nd, 2019
5.5K views
We describe both in vitro and in vivo infection assays that can be used to analyze the activities of host-encoding factors.
Overview
This article discusses techniques for analyzing the efflux of intracellular microbial pathogens. It highlights both in vitro and in vivo infection assays that can be utilized to evaluate the activities of host-encoding factors and the efficiency of pathogen efflux.
Key Study Components
Area of Science
- Microbial Pathogen Interactions
- Host-Pathogen Dynamics
- Infection Assays
Background
- Intracellular pathogens must exit host cells to propagate.
- Efflux mechanisms are relatively understudied compared to other host-pathogen interactions.
- Clear experimental controls are essential for accurate observations.
- Techniques can vary based on specific pathogen-host cell models.
Purpose of Study
- To describe methods for analyzing pathogen efflux.
- To evaluate efflux efficiency in various assays.
- To characterize post-efflux pathogens.
Methods Used
- In vitro infection assays
- In vivo infection assays
- Evaluation of efflux efficiency
- Characterization of post-efflux pathogens
Main Results
- Demonstrated techniques are broadly applicable.
- Assays can be adapted to different pathogens and host cells.
- Clear controls are vital for ensuring biological relevance.
- Procedure demonstrated by a graduate student from the laboratory.
Conclusions
- Understanding pathogen efflux is crucial for comprehending host-pathogen interactions.
- Simple assays can provide valuable insights into pathogen behavior.
- Future studies can build on these techniques to explore various pathogens.
Frequently Asked Questions
What are the main techniques discussed in the article?
The article discusses in vitro and in vivo infection assays to analyze pathogen efflux.
Why is pathogen efflux important?
Pathogen efflux is crucial for understanding how intracellular pathogens exit host cells and propagate.
What role do controls play in these experiments?
Clear controls ensure that genuine biological processes are observed in experimental samples.
Who demonstrated the procedures in the study?
The procedures were demonstrated by Petoria Gayle, a graduate student from the laboratory.
Can these techniques be applied to different pathogens?
Yes, the techniques are broadly applicable but may require adaptation for specific pathogens.
What is the significance of this research?
This research provides insights into pathogen behavior and can inform future studies on host-pathogen interactions.
Executive Industry Relevance
Understanding pathogen efflux mechanisms provides critical insights into host-pathogen dynamics, enabling target validation for anti-infective strategies. Quantitative assays for cellular efflux support mechanistic de-risking in early discovery by linking pathogen factors to host responses. This approach enhances predictive confidence in identifying modulators of eukaryotic cell function relevant to therapeutic intervention.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by quantifying pathogen efflux as a functional readout of host cellular processes.
- Operational Value: Enables biological de-risking through standardized measurement of intracellular pathogen recovery and proliferation.
- Predictive Value: Supports portfolio triage by correlating pathogen strain variations (e.g., prfA status) with efflux efficiency and intracellular survival.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for high-throughput screening by establishing reproducible efflux assays using CFU and flow cytometry.
- Operational Value: Addresses assay standardization through defined controls (e.g., gentamicin protection, no-cell wells) ensuring signal dependence on host cells.
- Scalability: Highlights readiness for discovery-based screens due to simplicity and scalability of water lysate dilution and plating protocols.
Translational & Preclinical Research
- Translational Continuity: Demonstrates close correspondence between in vitro cultured cell infection and in vivo hepatic cell responses, supporting extrapolation to physiological contexts.
- Mechanistic De-risking: Focuses on pathogen- and host-encoded factors impacting efflux, enabling risk-adjusted advancement decisions based on functional validation.
- Predictive Confidence: Connects efflux efficiency to intracellular proliferation dynamics, informing dose-response and timing considerations in preclinical models.
Pipeline & Workflow Integration
Positioned within early discovery to lead identification, this method supports hypothesis testing, assay readiness, and quantitative analytics critical for downstream decision-making.
- Discovery Biology: Supports hypothesis testing by linking pathogen efflux to host cytoskeletal dynamics via phalloidin staining and size gating in flow cytometry.
- Screening: Describes assay readiness through standardized infection, antibiotic treatment, and lysis protocols enabling consistent quantitative outputs.
- Analytics: Highlights CFU enumeration and flow cytometry as quantitative readouts that enable comparison of efflux efficiency across conditions and time points.
- Translational Research: Connects method to preclinical continuity via demonstrated correlation between in vitro and in vivo hepatic cell infection dynamics.
- Enterprise Reuse: Frames the efflux assay as a reusable platform for testing pathogen, host, or small molecule modulators across discovery campaigns.
Operational & Enterprise Impact
- Scientific Value: Provides predictive confidence in target validation by reducing mechanistic ambiguity in pathogen-host interactions.
- Operational Value: Ensures standardization and reproducibility through defined controls and scalable assay formats.
- Strategic Value: Improves go/no-go decisions by enabling early detection of efflux-modulating compounds with reduced late-stage biological risk.
- Portfolio Impact: Supports risk-adjusted prioritization through quantifiable efflux efficiency linked to pathogenic fitness and host adaptation.
Implementation Considerations
- Requires expertise in microbiological techniques, tissue culture, and flow cytometry for accurate pathogen quantification and host response assessment.
- Dependent on instrumentation including centrifuges, vortexers, automated cell counters, and flow cytometers for lysate processing and signal detection.
- Necessitates cross-team standardization of infection timing, antibiotic concentrations, and dilution protocols to ensure reproducibility across laboratories.
- Involves adaptation considerations when extending to different pathogen-host cell models due to variations in kinetics, dosages, and read-outs as noted in the source.
- Includes practical limitations such as the need for careful avoidance of well wall contact during inoculation and strict adherence to timing for gentamicin treatment to distinguish intracellular from extracellular pathogens.
Biopharma FAQs
Why does quantifying pathogen efflux matter for target validation?
Quantifying pathogen efflux enables measurement of host cellular processes involved in pathogen exit, providing a functional assay to validate targets that modulate eukaryotic cell function critical for anti-infective development.
How does isolating the independent variable of pathogen strain impact discovery pipeline decisions?
Isolating pathogen strain as an independent variable (e.g., wild-type vs. prfA mutant) allows direct assessment of virulence factors on efflux efficiency, supporting mechanistic de-risking and lead identification in early discovery.
What quantitative dependent variable measurements enable efflux efficiency assessment?
Colony-forming unit assays and flow cytometry measuring GFP-positive, phalloidin-associated bacterium-sized particles provide quantitative readouts of viable intracellular pathogen recovery and efflux efficiency over time.
Why do replication requirements matter for cross-functional collaboration in efflux studies?
Replication requirements ensure that observed efflux signals are biologically genuine and dependent on host cells, validated through no-cell controls and standardized protocols, enabling reliable data sharing across discovery teams.
What statistical analysis capabilities are required before implementing efflux assays in screening campaigns?
Implementation requires capability to analyze fold-change in pathogen recovery (e.g., fourfold and seven-point-fivefold increases) and statistical comparison of efflux efficiency across conditions, time points, and genetic or chemical modulators.
Chapters in this video
0:04
Title
1:08
Infection Procedures
2:16
Sampling Processing of Intracellular and Emergent Lm for Colony-forming Unit (CFU) Assay
3:58
Sampling Processing of Intracellular and Emergent Lm for Flow Cytometry (FCM)
6:22
Results: The Role of Pathogen and Host-encoded Factors on Cellular Infection
7:54
Conclusion
